Patents by Inventor Marjaneh Razmara

Marjaneh Razmara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fn 14/TRAIL Fusion Proteins
    Publication number: 20130065815
    Abstract: Fusion proteins which act on the TWEAK and TRAIL signaling axes are provided. The proteins are useful in the treatment or amelioration of autoimmune diseases, particularly multiple sclerosis, as well as other diseases such as alloimmune diseases and cancer.
    Type: Application
    Filed: August 15, 2012
    Publication date: March 14, 2013
    Inventors: Mark L. Tykocinski, Marjaneh Razmara
  • Fn14/TRAIL fusion proteins and method of treating cancer
    Patent number: 8329657
    Abstract: Fusion proteins which act on the TWEAK and TRAIL signaling axes are provided. The proteins are useful in the treatment or amelioration of autoimmune diseases, particularly multiple sclerosis, as well as other diseases such as alloimmune diseases and cancer.
    Type: Grant
    Filed: August 11, 2011
    Date of Patent: December 11, 2012
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Mark L. Tykocinski, Marjaneh Razmara
  • FN14/TRAIL Fusion Proteins
    Publication number: 20120028909
    Abstract: Fusion proteins which act on the TWEAK and TRAIL signaling axes are provided.
    Type: Application
    Filed: August 11, 2011
    Publication date: February 2, 2012
    Inventors: Mark L. Tykocinski, Marjaneh Razmara
  • Fn14/TRAIL fusion proteins
    Patent number: 8039437
    Abstract: Fusion proteins which act on the TWEAK and TRAIL signaling axes are provided. The proteins are useful in the treatment or amelioration of autoimmune diseases, particularly multiple sclerosis, as well as other diseases such as alloimmune diseases and cancer.
    Type: Grant
    Filed: June 30, 2009
    Date of Patent: October 18, 2011
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Mark L. Tykocinski, Marjaneh Razmara
  • FN14/TRAIL FUSION PROTEINS
    Publication number: 20100048478
    Abstract: Fusion proteins which act on the TWEAK and TRAIL signaling axes are provided. The proteins are useful in the treatment or amelioration of autoimmune diseases, particularly multiple sclerosis, as well as other diseases such as alloimmune diseases and cancer.
    Type: Application
    Filed: June 30, 2009
    Publication date: February 25, 2010
    Inventors: Mark L. Tykocinski, Marjaneh Razmara